Table 2.
Effects of drugs on gastrointestinal transit
Parameter | Placebo | Tolterodine | Darifenacin (7.5 mg) | Darifenacin (15 mg) |
---|---|---|---|---|
Gastric emptying, thalf, min | 125.5 ± 6.7 | 127 ± 6.4 | 115.4 ± 6.4 | 120.4 ± 6.7 |
Colonic filling at 6 h, % | 59.6 ± 6.4 | 47.1 ± 6 | 34.4 ± 6.1† | 20.4 ± 6.3†‡ |
Colonic transit | ||||
Ascending colonic emptying, thalf, h | 12.0 ± 1.5 | 14.0 ± 1.0 | 18.6 ± 1.9* | 22.9 ± 2.6†‡ |
GC24 | 2.8 ± 0.2 | 2.7 ± 0.2 | 2.4 ± 0.2 | 1.9 ± 0.2†‡ |
GC48 | 3.8 ± 0.2 | 4 ± 0.2 | 3.6 ± 0.2 | 3.4 ± 0.2 |
All values represent least squares means (95% CI), adjusted for gender and BMI. GC24 and GC48, geometric center of oclonic transit at 24 and 48 h, respectively.
P = 0.02;
P < 0.01 vs. placebo;
P < 0.01 vs. tolterodine.